Paris, October 9, 2024. Sanofi advances its ambition to protect all infants from respiratory syncytial virus (RSV) disease with new Beyfortus (nirsevimab) data to be presented at the Infectious ...

Sanofi to present data from Beyfortus to treat RSV diseases at IDWeek 2024 annual meeting: Paris Thursday, October 10, 2024, 12:00 Hrs [IST] Sanofi advances its ambition to protec ...

Sanofi - Aventis Groupe said that the data featured at IDWeek from several national immunization programs will reinforce the proven ...

The Nobel Prize in medicine was awarded to Victor Ambros, PhD, of the University of Massachusetts, and Gary Ruvkun, PhD, of ...

Mpox – formerly known as monkeypox – is rapidly spreading in several African countries, prompting the World Health ...

The World Health Organization recommended vaccinating pregnant women and administering infants with an antibody to prevent severe respiratory synctial virus (RSV) infection in newborns.

One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years ...

Thermo Fisher's Greenville facility, one of the largest in the U.S., has faced repeated FDA regulatory violations. Key concerns include contamination prevention and inadequate equipment sterilization ...

Thermo Fisher's Greenville plant, a major contract drug manufacturer in the U.S., has faced repeated FDA scrutiny for contamination risks. Recent audits identified issues in the production of ...

One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years ...

One of the biggest contract drug manufacturing plants in the US owned by Thermo Fisher Scientific (NYSE: TMO) has repeatedly broken rules designed to ensure that ...